Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Inotiv, Inc. announced that the company has completed the purchase of Orient BioResource Center, Inc. (“OBRC”), from Orient Bio, Inc., a preclinical contract research organization and animal model supplier based in Seongnam, South Korea. Orient ...
read more
Inotiv, a leading contract research organization specializing in nonclinical and analytical drug discovery and development services, announced that the Company has completed the purchase of its previously leased St. Louis facility for approximately $...
read more
Bioanalytical Systems, doing business as Inotiv, announced I.M. Grossi, Ph.D., has joined the Company as Vice President, Toxicology.
read more
Inotiv announced an expanded capacity to conduct Good Laboratory Practices (“GLP”) studies for in vitro cytogenetics and bacterial mutation assays as components of the Standard Battery of genetic toxicology studies required for first-in-human ...
read more
Inotiv, Inc. announced the acquisition of Histion, LLC, effective April 25, 2022. The acquisition is a strategic element of the company’s expansion of its specialized pathology services.
read more
INOVIO has entered into an agreement to expand its manufacturing partnership with the German contract manufacturer Richter-Helm BioLogics GmbH & Co. KG, to support large-scale manufacturing of INOVIO's investigational DNA vaccine INO-4800.
read more
Monday, February 14, 2022
Curia, formerly AMRI, announced that Integrity Bio and LakePharma, two companies that it acquired last year, have fully transitioned to the Curia brand. This change reflects the accelerated organizational integration of the acquired companies into ...
read more
International Process Plants (IPP) announced its subsidiary Humber Industrials Ltd. has reached an agreement to purchase Novartis UK's 170-acre active pharmaceutical ingredient (API) manufacturing plant site and assets in Grimsby, UK.
read more
Wednesday, March 11, 2020
International Pharmaceutical Expo (INTERPHEX) will be postponed due to the COVID-19 virus.
read more
Intravacc and Celonic have signed a research agreement to further design, develop and produce a Covid-19 vaccine.
read more
Thursday, January 21, 2021
Intravacc announced a candidate polyvalent inactivated coxsackievirus B vaccine it developed and manufactured for Provention Bio has entered into a first in human Phase I clinical study.
read more
Monday, February 22, 2021
Intravacc announced its new modern pilot production plant will soon be operational.
read more
Monday, November 06, 2017
InVitria has announced the launch of a new media formulation service at the international BIO-Europe conference in Berlin, Germany.
read more
IQVIA™, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, announced the opening of a state-of-the-art, 160,000-square-foot lab facility for its Q2 Solutions subsidiary...
read more
Irvine Pharmaceutical Services, a leading provider of cGMP contract development and manufacturing services for the pharmaceutical, biotech, and medical device industries since 1988, is pleased to announce it successfully completed a five day cGMP ...
read more